News
Lumexa Imaging Holdings
LMRI · NASDAQ
$10.68−$0.04 (−0.37%)TodayMarket closed ·
Prev close $10.72
Latest news
- Press releaseGlobe Newswire
Lumexa Imaging Announces Second Quarter 2026 Results
- Press releaseGlobe Newswire
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
- Press releaseGlobe Newswire
Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
Lumexa Imaging Holdings Q1 2026 Earnings Call Transcript
- News
Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M Estimate
- Press releaseGlobe Newswire
Lumexa Imaging Announces First Quarter 2026 Results
- News
Earnings Scheduled For May 12, 2026
- Press releaseGlobe Newswire
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
- News
Earnings Scheduled For March 26, 2026
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releaseBusiness Wire
Middleby Appoints Glenn Eisenberg To Board of Directors
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releasePRNewswire
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
- Press releasePRNewswire
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care
- Press releasePRNewswire
Lumexa Imaging Achieves Record De Novo Expansion in 2025
- Press releasePRNewswire
Lumexa Imaging Announces Participation in Upcoming Investor Conference
- NewsVandana Singh
Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO
- NewsAvi Kapoor
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- Press releasePRNewswire
Lumexa Imaging Announces Pricing of Initial Public Offering
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.